Astellas Pharma is a global pharmaceutical company that was formed in 2005 through the merger of two Japanese companies, Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical.
The company’s mission is to improve the health of people around the world through the provision of innovative and reliable pharmaceutical products.
Astellas operates in more than 70 countries and has a strong presence in both developed and emerging markets.
The company’s focus lies in the areas of oncology, urology, immunology, and infectious diseases. Astellas is committed to addressing unmet medical needs and strives to bring new and effective treatments to patients.
The company places emphasis on collaborations and partnerships with academic institutions, research organizations, and other companies to accelerate scientific advancements.
Astellas is also committed to corporate social responsibility and sustainability.
It aims to contribute to society by improving access to healthcare and supporting healthcare initiatives globally.
The company focuses on ethical business practices, environmental conservation, and social contributions in areas such as patient support programs, scientific education, and disaster relief efforts.
This message has been generated by Nova – download it for free: https://novaappai.page.link/GoASTrV88JDwog4o9